1. Home
  2. LGO vs PDSB Comparison

LGO vs PDSB Comparison

Compare LGO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Largo Inc.

LGO

Largo Inc.

HOLD

Current Price

$0.38

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.57

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGO
PDSB
Founded
1988
2005
Country
Canada
United States
Employees
N/A
10
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
42.4M
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
LGO
PDSB
Price
$0.38
$1.57
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $2.20
N/A
AVG Volume (30 Days)
751.2K
★ 11.2M
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.16
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.04
N/A
Revenue Next Year
$14.74
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.20
52 Week High
$1.93
$1.79

Technical Indicators

Market Signals
Indicator
LGO
PDSB
Relative Strength Index (RSI) 29.61 65.51
Support Level N/A $0.60
Resistance Level $0.82 $1.79
Average True Range (ATR) 0.03 0.22
MACD 0.00 0.01
Stochastic Oscillator 7.22 76.40

Price Performance

Historical Comparison
LGO
PDSB

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: